Patrick D. McGorry, MD, PhD

Taurine for First-Episode Psychosis

December 28, 2016

When your 18- to 26-year-old patients respond poorly to the antipsychotic prescribed for their first episode of psychosis, what else can you try? In this RCT, taurine, which acts...

Patrick D. McGorry, Tina-Marie Proffitt, Hok Pan Yuen, et al

Letter to the Editor

Dr McGorry and Colleagues Reply

November 15, 2013

Alison R. Yung, Patrick D. McGorry, G. Paul Amminger, et al

Original Research

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome

April 15, 2013

Alison R. Yung, Patrick D. McGorry, Gregor E. Berger, et al

Review Article

Overview of Violence to Self and Others During the First Episode of Psychosis

May 15, 2012

Patrick D. McGorry, Gin S. Malhi, Olav B. Nielssen, et al

Original Research

Randomized Controlled Trial of Interventions for Young People at Ultra High Risk for Psychosis: 6-Month Analysis

October 19, 2010

Alison R. Yung, Patrick D. McGorry, G. Paul Amminger, et al

Original Research

The EPPIC Follow-Up Study of First-Episode Psychosis: Longer-Term Clinical and Functional Outcome 7 Years After Index Admission

June 15, 2010

Henry J. Jackson, Patrick D. McGorry, Hok Pan Yuen, et al

Original Research

Family Outcomes From a Randomized Control Trial of Relapse Prevention Therapy in First-Episode Psychosis

December 15, 2009

Mario Álvarez-Jiménez, Patrick D. McGorry, Darryl Wade, et al

Original Research

Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions

June 30, 2009

Alison R. Yung, Merete Nordentoft, Patrick D. McGorry, et al

Original Research

A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients

March 24, 2009

Mario Álvarez-Jiménez, Patrick D. McGorry, Darryl Wade, et al

Original Research

Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years

November 30, 2008

Patrick D. McGorry, Gregor E. Berger, Tina-Marie Proffitt, et al

Original Research

Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis: A Randomized, Placebo-Controlled Trial

December 14, 2007

Patrick D. McGorry, Gregor E. Berger, Tina-Marie Proffitt, et al

Article

Impact of Severity of Substance Use Disorder on Symptomatic and Functional Outcome in Young Individuals With First-Episode Psychosis

May 15, 2007

Patrick D. McGorry, Darryl Wade, Philip M. Burgess, et al

Taurine for First-Episode Psychosis

Dr McGorry and Colleagues Reply

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome

Overview of Violence to Self and Others During the First Episode of Psychosis

Randomized Controlled Trial of Interventions for Young People at Ultra High Risk for Psychosis: 6-Month Analysis

The EPPIC Follow-Up Study of First-Episode Psychosis: Longer-Term Clinical and Functional Outcome 7 Years After Index Admission

Family Outcomes From a Randomized Control Trial of Relapse Prevention Therapy in First-Episode Psychosis

Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions

A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients

Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years

Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis: A Randomized, Placebo-Controlled Trial

Impact of Severity of Substance Use Disorder on Symptomatic and Functional Outcome in Young Individuals With First-Episode Psychosis

ELSEWHERE:

FOLLOW US:

Patrick D. McGorry, MD, PhD

Taurine for First-Episode Psychosis

Dr McGorry and Colleagues Reply

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome

Overview of Violence to Self and Others During the First Episode of Psychosis

Randomized Controlled Trial of Interventions for Young People at Ultra High Risk for Psychosis: 6-Month Analysis

The EPPIC Follow-Up Study of First-Episode Psychosis: Longer-Term Clinical and Functional Outcome 7 Years After Index Admission

Family Outcomes From a Randomized Control Trial of Relapse Prevention Therapy in First-Episode Psychosis

Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions

A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients

Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years

Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis: A Randomized, Placebo-Controlled Trial

Impact of Severity of Substance Use Disorder on Symptomatic and Functional Outcome in Young Individuals With First-Episode Psychosis

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles